Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Teva introduces Pristiq generic
JERUSALEM, Israel — Teva Pharmaceuticals on Wednesday introduced generic Pristiq (desvenlafaxine) extended-release tablets, 25, 50 and 100 mg, in the United States.
Kite Announces Positive Topline Primary Results of Axicabtagene Ciloleucel from First Pivotal CAR-T Trial in Patients with Aggressive Non-Hodgkin Lymphoma
SANTA MONICA, Calif.
Juno ends development of high-profile leukemia drug after deaths
Juno Therapeutics Inc on Wednesday said it decided to shut down development of an experimental leukemia treatment from a highly promising new class of immunotherapy following an investigation into tox...
Accera's Alzheimer's trial fails, in yet another setback for disease
Nestle SA-backed Accera Inc said on Tuesday its experimental Alzheimer's drug failed a late-stage study, adding to the laundry list of disappointments in the pursuit of an effective treatment for ...
FDA approves Perrigo’s hydrocodone bitartrate and homatropine methylbromide
WASHINGTON — The U.
FDA Approves Qtern
28 February 2017 -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily Qtern (10mg dapagliflozin and 5mg saxagliptin) for the treatment ...
FDA approves Xermelo for carcinoid syndrome diarrhea
The U.
Stada recieves a $3.7 billion offer
German company announced that Boston private equity outfit Advent International had put up a legally binding bid of €58 per share in cash, plus a 2016 dividend payment; in 2015, that payment amounte...
Merck drug prevents serious infection after marrow transplant: study
An experimental Merck & Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was associated with a lower death rate compared with p...
Six new medicines endorsed for EU approval
Six new medicines, including the first hormone replacement therapy for a thyroid disorder, have been put forward for approval by the European Medicines Agency's Committee for Medicinal Products fo...
Health care leaders gather in Washington
WASHINGTON — Leaders across the health care continuum on Thursday gathered in Washington, D.
Sanofi and Lonza will build new $285 million biologics facility
French drugmaker Sanofi and Swiss manufacturer Lonza will invest 270 million euros ($285 million) in a new large-scale biologics facility that will produce monoclonal antibodies by 2020.
529
530
531
532
533
534
535
536
537
